M062 Is a Host Range Factor Essential for Myxoma Virus Pathogenesis and Functions as an Antagonist of Host SAMD9 in Human Cells
- 1 April 2011
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (7), 3270-3282
- https://doi.org/10.1128/jvi.02243-10
Abstract
Myxoma virus (MYXV) M062R is a functional homolog of the C7L family of host range genes from orthopoxviruses. We constructed a targeted M062R-knockout-MYXV (vMyxM062-KO) and characterized its properties in vitro and in vivo . In European rabbits, infection by vMyxM062-KO was completely asymptomatic. The surviving rabbits did not gain full protection against the subsequent lethal-dose challenge with wild-type MYXV. We also looked for cellular tropism defects in a variety of cultured cells. In all of the rabbit cells tested, vMyxM062-KO conducts an abortive infection, although it initiates viral DNA replication. In many, but not all, human cancer cells that are permissive for wild-type MYXV, vMyxM062-KO exhibited a profound replication defect. We categorized human cells tested into two groups: (i) type A, which support productive replication for wild-type MYXV but are unable to produce significant levels of progeny virus by vMyxM062-KO, and (ii) type B, which are permissive to infections by both wild-type MYXV and vMyxM062-KO. Furthermore, using proteomic strategies, we identified sterile α motif domain containing 9 (SAMD9), an interferon-regulated cellular protein implicated in human inflammatory disorders, as a unique host binding partner of M062 in human cells. Significantly, knocking down SAMD9 in type A human cancer cells led to a substantial rescue of vMyxM062-KO infection. In summary, M062 is a novel host range factor that controls productive MYXV replication in rabbit cells and in a wide variety of human cells. M062 also binds and antagonizes cellular SAMD9 in human cells, suggesting that SAMD9 is a novel innate antiviral factor against poxviruses.Keywords
This publication has 23 references indexed in Scilit:
- Functional Characterization of SAMD9, a Protein Deficient in Normophosphatemic Familial Tumoral CalcinosisJournal of Investigative Dermatology, 2011
- The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeuticsMicrobes and Infection, 2010
- Myxoma Virus: Propagation, Purification, Quantification, and StorageCurrent Protocols in Microbiology, 2010
- Vaccinia Virus K1L and C7L Inhibit Antiviral Activities Induced by Type I InterferonsJournal of Virology, 2009
- Myxoma Virus Expressing Interleukin-15 Fails To Cause Lethal Myxomatosis in European RabbitsJournal of Virology, 2009
- TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupusThe Journal of Experimental Medicine, 2008
- Reduction in Severity of a Herpes Simplex Virus Type 1 Murine Infection by Treatment with a Ribozyme Targeting the U L 20 Gene RNAJournal of Virology, 2008
- Normophosphatemic Familial Tumoral Calcinosis Is Caused by Deleterious Mutations in SAMD9, Encoding a TNF-α Responsive ProteinJournal of Investigative Dermatology, 2008
- Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7LVirology, 2008
- A Deleterious Mutation in SAMD9 Causes Normophosphatemic Familial Tumoral CalcinosisAmerican Journal of Human Genetics, 2006